Victoria Hooton,Elizabeth Chloe Romanis
Victoria Hooton
This article considers challenges for the European Union (EU) maternity and pregnancy rights framework when faced with advances in reproductive technology. Specifically, we consider how the introduction of the 'artificial womb' technology, ...
Reforming the countermeasures injury compensation program for COVID-19 and beyond: An economic perspective [0.03%]
从经济学角度看新冠肺炎及未来疫情的对策伤害补偿计划改革
Junying Zhao,Firat Demir,Pallab K Ghosh et al.
Junying Zhao et al.
As of Aug. 2, 2021, 1693 injury claims associated with COVID-19 medical countermeasures have been filed in the Countermeasures Injury Compensation Program (CICP), of which 686 claims were related to COVID-19 vaccines and urgently needed com...
Alexander Bernier,Fruzsina Molnár-Gábor,Bartha Maria Knoppers
Alexander Bernier
As the adoption of digital health accelerates health research increasingly relies on large quantities of biomedical data. Research institutions scattered across a large number of jurisdictions collaborate in producing and analyzing biomedic...
Kunal K Sindhu,Adam C Schaffer,I Glenn Cohen et al.
Kunal K Sindhu et al.
The Federation of State Medical Boards defines physician sexual misconduct as any 'behavior that exploits the physician-patient relationship in a sexual way.' Although several attempts have been made in recent years to clarify its incidence...
Jonathan Pugh,Dominic Wilkinson,Ian Kerridge et al.
Jonathan Pugh et al.
In early 2021, cases of rare adverse events were observed in individuals who had received the Astra Zeneca COVID-19 vaccine. Countries around the world differed radically in their policy responses to these observations. In this paper, we ou...
Pain that only she must bear: on the invisibility of women in judicial abortion rhetoric [0.03%]
她痛，众人不知——论司法堕胎论述中女性的缺席状态
F Laguardia
F Laguardia
The graphic and bodily facts of a legal question of rights are relevant to the courts, particularly in questions that directly implicate physical bodies and pain, such as right to die cases, or what level of search may be allowable and when...
When speed matters: a discussion on the benefits of a grace period in patent law to accelerate pharmaceutical innovation in times of pandemic [0.03%]
速度至上：论专利法中的宽限期条款在疫情期间加速医药创新的好处
Tomasz Ozyhar,Laura Barnabei,Dorkina Myrick
Tomasz Ozyhar
The unprecedented coronavirus disease 2019 (COVID-19) pandemic is a solemn reminder of the need to accelerate pharmaceutical innovation. The desire for fast access to vaccines triggered discussion of unrestricted access to research findings...
Competition law and pricing among biologic drugs: the case of VEGF therapy for retinal diseases [0.03%]
生物类似药的竞争法与定价：以血管内皮生长因子治疗视网膜疾病为例
Victor L Van de Wiele,Maximilian Hammer,Ravi Parikh et al.
Victor L Van de Wiele et al.
Neovascular age-related macular degeneration (AMD) is a progressive eye disease and is a leading cause of vision loss in the Western world. Vascular endothelial growth factor inhibitors have become a mainstay of treatment for this disease. ...
Heritable genome editing and cognitive biases: why broad societal consensus is the wrong standard for moving forward [0.03%]
可遗传基因组编辑和认知偏差：为什么不应以广泛的社会共识作为继续发展的标准
Kerry Lynn Macintosh
Kerry Lynn Macintosh
Heritable genome editing (HGE) may one day safely correct mutations that cause serious monogenic diseases. Nevertheless, some scientists and bioethicists argue that HGE should be subject to a moratorium. In their view, no nation should proc...
Inherited regulation for advanced ARTs: comparing jurisdictions' applications of existing governance regimes to emerging reproductive technologies [0.03%]
现有治理制度在新兴生殖技术中的运用及其比较研究
Walter G Johnson,Diana M Bowman
Walter G Johnson
Over the past 5 years, advanced assisted reproductive technologies (ARTs), such as mitochondrial replacement therapies (MRTs) and heritable human genome editing (HHGE), have raised global policy concerns and fears of 'unregulated' prolifera...